Who is sponsoring NCT00713557?

NCT00713557 is sponsored by Shanghai Jiao Tong University School of Medicine.

What condition does NCT00713557 study?

NCT00713557 studies Coronary Artery Disease, Acute Coronary Syndrome.

What drugs are being tested in NCT00713557?

Interventions: drug-eluting stent, Tirofiban.

What is the status of NCT00713557?

NCT00713557 is currently TERMINATED.

Last reviewed 2016-10-12 · How we verify

Phase 4 Study to Compare Different Therapeutic Strategies for Patients With ACS

NCT00713557 TERMINATED

SRACE is an multicenter observational database of outcomes for patients who are hospitalized with an acute coronary events. SRACE includes over 20 hospitals in Shanghai China that have enrolled a total of more than 3,000 patients since 2005, with an annual enrollment of 500 patients. The major purpose of the SRACE program is to evaluate the prognosis of patients admitted to the hospital due to acute coronary events, comparing different therapeutic strategies, in-hospital transferring system, and so on. All participating physicians receive confidential quarterly reports showing ther outcomes side-by-side with the aggregate outcomes of all participating hospitals.

Details

Lead sponsor	Shanghai Jiao Tong University School of Medicine
Status	TERMINATED
Enrolment	20000
Start date	2005-03

Conditions

Coronary Artery Disease
Acute Coronary Syndrome

Interventions

drug-eluting stent
Tirofiban

Primary outcomes

major adverse cardiac events(MACE), including death, non-fatal re-MI, and target vessel revascularization — in-hospital, 30d, and long-term follow-up

Countries

China